Panbela Therapeutics SMA 50
¿Qué es el SMA 50 de Panbela Therapeutics?
El SMA 50 de Panbela Therapeutics Inc. es $0 -11.64%
¿Cuál es la definición de SMA 50?
SMA 50 es un precio promedio de las acciones de los últimos 50 días calculado como una media no ponderada de los previos 50 precios de cierre de acciones.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 de compañías en Sector Health Care en NASDAQ en comparadas con Panbela Therapeutics
¿Qué hace Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Empresas con sma 50 similar a Panbela Therapeutics
- Greenstone Capital tiene SMA 50 de CAD$0 -500.00%
- Mastrad Société Anonyme tiene SMA 50 de $0 +0.61%
- Applied Genetic Technologies Corp tiene SMA 50 de $0 +0.00%
- Pacifico Minerals tiene SMA 50 de AUD$0 +99.70%
- Dxi Capital Corp tiene SMA 50 de $0 +98.70%
- Summa Silver tiene SMA 50 de CAD$0 -10.05%
- Panbela Therapeutics tiene SMA 50 de $0 -11.64%
- Elate tiene SMA 50 de HKD$0 +11.10%
- QUHUO Ltd tiene SMA 50 de $0 +76.29%
- Doubleview Gold Corp tiene SMA 50 de CAD$0 -4.34%
- Changmao Biochemical Engineering tiene SMA 50 de HKD$0 +14.81%
- Artini tiene SMA 50 de HKD$0 -7.49%
- Beijing Media tiene SMA 50 de HKD$0 -2.01%